THE FIRST STEP TO PERSONALIZE AUTOIMMUNE DISEASE TREATMENT

We aim to develop novel IVD tools based on our Immunobiogram platform for autoimmune diseases, and other immune-based conditions, including (but not only) rheumatoid arthritis and lupus nephritis.

Ultimately, we strive to become a versatile IVD company with a large portfolio in immune-based indications.

Renal, liver, heart, and others

0
transplants per year

After renal, liver is the most common transplant.

Over 100 different diseases

0M
patients

Mortality is increased greatly due to chronic inflammation and cardiovascualr diseases when these patients do not respond to treatment.

Cancer immunotherapy

0M
patients

Metastatic cancer is often treated with immunotherapy, but only a part of the patients respond to it.